Truveta

As a collaboration of top U.S. health systems, Truveta leverages data from over 120 million patients to power medical research and improve healthcare. Through AI technology and projects like the Truveta Genome Project, it focuses on advancing health equity and accelerating medical innovation.

NewsHeat chart

Week
Month
Year

Media news
Corp news

Click to unlock the chart

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

Valuation
Share Price
Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round

Funding Amount

Post-Money Valuation

Share Price

Venture13 Jan, 2025

***

Venture9 Nov, 2021

***

Corporate29 Sep, 2021

***

Series A13 Jul, 2021

***

*** - To view the data, please log into your account or create a new one.

News related to Truveta2

Sort by

Truveta

Jan 19, 2025 •Show on chart

Truveta sells stakes to Regeneron, Illumina in deal to build genetic ...

By Amina Niasse NEW YORK (Reuters) - Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals, Illumina and 17 U.S. health ...

https://www.msn.com/ar-eg/health/other/truveta-sells-stakes-to-regeneron-illumina-in-deal-to-build-genetic-database/ar-BB1rmv23

Truveta

Jan 13, 2025 •Show on chart